The deal looks good on paper. I am just wondering what type of damage existing employees can expect once the deal goes through. To the expert, do the companies have a lot of overlap in the life sciences divisions?

In any regards, best wishes to all shareholders and employees. Here is the article: http://unchartedstocks.com/2009/07/27/tw...